Michael Gelband’s Cano Health, Inc. CANO Stock Holding History

Michael Gelband’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,429	Closed	-$626K	–	2428
2022 Q2	$626K	Sell	1,429 -18	-1%	-$9.39K	0.01%	1273
2022 Q1	$919K	Buy	1,447 +735	+103%	+$463K	0.01%	1212
2021 Q4	$634K	Buy	+712	New	+$748K	0.01%	1275
2021 Q3	–	Sell	-476	Closed	-$576K	–	2809
2021 Q2	$576K	Buy	+476	New	+$642K	0.01%	1290

Other funds holding CANO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Michael Gelband's CANO Position: Q3 2022 in Review

Michael Gelband sold out of Cano Health, Inc. (CANO) in Q3 2022, closing a stake of 1,429 shares — an estimated $626K sold.

Michael Gelband first reported a position in CANO in Q2 2021 and held it in 4 quarters. The position peaked at $919K in Q1 2022. 173 funds tracked by Wall St. Rank hold CANO as of Q3 2022.

Michael Gelband reported no remaining Cano Health, Inc. position as of Q3 2022 after selling out during the quarter.
Michael Gelband sold 1,429 Cano Health, Inc. shares in Q3 2022, an estimated $626K.
Michael Gelband first reported a position in Cano Health, Inc. in Q2 2021 and held it in 4 quarters.
Michael Gelband's Cano Health, Inc. position peaked at $919K in Q1 2022.
173 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.